Abstract

BackgroundWharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) are gaining increasing interest as an alternative source of stem cells for regenerative medicine applications. Definitive endoderm (DE) specification is a prerequisite for the development of vital organs such as liver and pancreas. Hence, efficient induction of the DE lineage from stem cells is crucial for subsequent generation of clinically relevant cell types. Here we present a defined 3D differentiation protocol of WJ-MSCs into DE cells.MethodsWJ-MSCs were cultured in suspension to generate spheroids, about 1500 cells each, for 7 days. The serum-free differentiation media contained specific growth factors, cytokines, and small molecules that specifically regulate signaling pathways including sonic hedgehog, bone morphogenetic protein, Activin/Wnt, and Notch.ResultsWe obtained more than 85 % DE cells as shown with FACS analysis using antibodies directed against the DE marker CXCR4. In addition, biochemical and molecular analysis of bona-fide DE markers revealed a time-course induction of Sox17, CXCR4, and FoxA2. Focused PCR-based array also indicated a specific induction into the DE lineage.ConclusionsIn this study, we report an efficient serum-free protocol to differentiate WJ-MSCs into DE cells utilizing 3D spheroid formation. Our approach might aid in the development of new protocols to obtain DE-derivative lineages including liver-like and pancreatic insulin-producing cells.Electronic supplementary materialThe online version of this article (doi:10.1186/s13287-016-0426-9) contains supplementary material, which is available to authorized users.

Highlights

  • Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) are gaining increasing interest as an alternative source of stem cells for regenerative medicine applications

  • Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) have attracted tremendous interest in recent years as a potential stem cell source for both research and therapeutic applications because they displayed a high capacity for selfrenewal, multilineage differentiation, and immune-modular

  • We present a novel three-dimensional (3D), fully defined, serum-free, stepwise differentiation protocol to generate Definitive endoderm (DE) from WJ-MSCs

Read more

Summary

Introduction

Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) are gaining increasing interest as an alternative source of stem cells for regenerative medicine applications. Pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have been successfully differentiated into definitive endoderm (DE) and their derived lineages following extensive in-vitro induction protocols. Bhandari et al [7] reported successful differentiation of WJ-MSCs into DE, pancreatic foregut, pancreatic endoderm, and β-cells following a 1-week differentiation protocol. Another group managed to differentiate WJ-MSCs into insulin-producing cells in vitro [12]. Adherence to clinical scale standards requires genomic modification of the free cell type, and the development of highly efficient differentiation protocols free from animal products and chemically defined with detailed acknowledgment of the small molecules used to mediate differentiation

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call